Homocysteine, renal function, and risk of cardiovascular disease.

Homocysteine, renal function, and risk of cardiovascular disease.

BACKGROUND: Patients with renal impairment have markedly elevated homocysteine levels and are at particularly high risk of ischemic heart disease (IHD) and stroke, but the relevance of elevated homocysteine levels in this population is uncertain. METHODS: We examined the association with IHD from a...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Clarke, R, Lewington, S, Landray, M
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2003

समान संसाधन

Homocysteine and risk of cardiovascular disease and venous thrombosis
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2003)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
द्वारा: Clarke, R
प्रकाशित: (2011)

Renal function: an emerging risk factor for cardiovascular disease?
द्वारा: Landray, M, और अन्य
प्रकाशित: (2001)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2007)

Homocysteine and cardiovascular disease. Overview.
द्वारा: Clarke, R
प्रकाशित: (1998)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2005)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2001)

Homocysteine and coronary heart disease.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2002)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2011)

Homocysteine and prediction of coronary heart disease and stroke
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2003)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
द्वारा: Clarke, R
प्रकाशित: (2009)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
द्वारा: Clarke, R
प्रकाशित: (2002)

Homocysteine, B vitamins, and cardiovascular disease
द्वारा: Refsum, H, और अन्य
प्रकाशित: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
द्वारा: Refsum, H, और अन्य
प्रकाशित: (2006)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2001)

Homocysteine and malondialdeyde (MDA) levels associated with the occurrence of cardiovascular disease (CVD) in chronic renal failure (CRF) in Malaysia.
द्वारा: Arab, Shahin, और अन्य
प्रकाशित: (2011)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2000)

Homocysteine, the kidney, and vascular disease.
द्वारा: Haynes, R, और अन्य
प्रकाशित: (2012)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
द्वारा: Den Heijer, M, और अन्य
प्रकाशित: (2005)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk
द्वारा: Lewington, S, और अन्य
प्रकाशित: (2005)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
द्वारा: Lewington, S, और अन्य
प्रकाशित: (2005)

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
द्वारा: Haynes, R, और अन्य
प्रकाशित: (2012)

Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
द्वारा: Ueland, P, और अन्य
प्रकाशित: (2007)

Homocysteine, B vitamins, and the risk of dementia.
द्वारा: Clarke, R
प्रकाशित: (2007)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (2007)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
द्वारा: Clarke, R, और अन्य
प्रकाशित: (1998)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
द्वारा: Danesh, J, और अन्य
प्रकाशित: (1998)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
द्वारा: Holman, R, और अन्य
प्रकाशित: (2001)

Homocysteine-lowering trials for prevention of heart disease and stroke.
द्वारा: Clarke, R
प्रकाशित: (2005)

Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
द्वारा: Landray, M, और अन्य
प्रकाशित: (2001)

Which cardiovascular risk factors matter in chronic kidney disease?
द्वारा: Baigent, C, और अन्य
प्रकाशित: (2007)

Homocysteine: a risk factor for coronary artery disease?
द्वारा: Marinou, K, और अन्य
प्रकाशित: (2005)

Atrial fibrillation and the risks of cardiovascular disease, renal disease and death: a meta-analysis
द्वारा: Odutayo, A, और अन्य
प्रकाशित: (2016)

Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.
द्वारा: Wheeler, D, और अन्य
प्रकाशित: (2003)

Premature cardiovascular disease in chronic renal failure.
द्वारा: Baigent, C, और अन्य
प्रकाशित: (2000)

Uncontrolled hypertension and risk of cardiovascular mortality in China-reply
द्वारा: Lewington, S, और अन्य
प्रकाशित: (2016)

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis
द्वारा: Odutayo, Ayodele, और अन्य
प्रकाशित: (2017)

Niacin for reduction of cardiovascular risk.
द्वारा: Landray, M, और अन्य
प्रकाशित: (2014)

Niacin for reduction of cardiovascular risk.
द्वारा: Landray, M, और अन्य
प्रकाशित: (2014)